Clinical Lab News

In a proof-of-concept study, the test detected five key biomarkers of Alzheimer’s disease—more than current commercially available blood tests can measure

Not only will the elimination of CLIAC have a negative impact on patient care, it also isn’t likely to result in meaningful savings for the government

Genetic factors contribute to some 30 percent of breast cancer cases in South Africa, necessitating investment in genomic research in African contexts

Even small tissue samples can yield additional insights into a tumor’s biology, immune interactions, and molecular pathways

Researchers estimated about 8,500 tons of antibiotics end up in river systems each year after passing through the human body and wastewater systems

The College of Nursing and Innovation’s Center for Rural Health and Nursing launches cutting-edge unit to tackle workforce and training challenges

The FY2026 budget proposal includes devastating cuts to NIH of $18 billion, which would result in a nearly 40 percent cut in NIH’s budget for lifesaving research

Prior to the MSDA Test, disease management in MS relied primarily on clinical assessments and MRI

First multicenter study of cell-free RNA and DNA methylation biomarkers in seminal fluid shows promise for accurate, noninvasive detection of clinically significant prostate cancer

Even at current immunization rates, researchers predict that measles may become endemic again

The AACR Trailblazer Cancer Research Grant Program will award $15 million over three years

A new report evaluates the economic fallout of US tariffs across six potential future scenarios, from unilateral US actions to a full-scale global trade war

This new publication sets the standard, enabling more personalized and targeted breast cancer prevention and detection

The results could spur more rigorous preventive measures that stop hidden spread of the disease

A new study finds that many eligible patients who receive other preventive screenings are not getting screened for lung cancer

Among the pregnant women, the researchers found that certain groups had higher Long COVID risks than others

The FDA LDT rule would have imposed unnecessary burdens on laboratories, adding requirements beyond existing CLIA regulations

About 1,900 scientists warn that actions being taken by the current administration will slow scientific advances and harm Americans

Professor Mark Peifer explains why understanding the history of eugenics is critical for up-and-coming scientists

Some people may require a second dose of the vaccine, as a single dose may fail to offer sufficient protection